Order Article Reprints

Pinto M, Fernandes C, Martins E, Silva R, Benfeito S, Cagide F, Mendes RF, Almeida Paz FA, Garrido J, Remião F, et al. Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. Pharmaceutics. 2019; 11(7):331. https://doi.org/10.3390/pharmaceutics11070331

Pinto, Miguel, Carlos Fernandes, Eva Martins, Renata Silva, Sofia Benfeito, Fernando Cagide, Ricardo F. Mendes, Filipe A. Almeida Paz, Jorge Garrido, Fernando Remião, and et al. 2019. "Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles" Pharmaceutics 11, no. 7: 331. https://doi.org/10.3390/pharmaceutics11070331

Pinto, M., Fernandes, C., Martins, E., Silva, R., Benfeito, S., Cagide, F., Mendes, R. F., Almeida Paz, F. A., Garrido, J., Remião, F., & Borges, F. (2019). Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles. Pharmaceutics, 11(7), 331. https://doi.org/10.3390/pharmaceutics11070331